Cue Biopharma Inc
General ticker "CUE" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $55.4M
Cue Biopharma Inc does not follow the US Stock Market performance with the rate: -32.4%.
Estimated limits based on current volatility of 5.4%: low 0.98$, high 1.10$
Factors to consider:
- Current price 44.7% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.88$, 4.36$]
- 2024-12-30 to 2025-12-30 estimated range: [1.91$, 4.39$]
Short-term CUE quotes
Long-term CUE plot with estimates
Financial data
| YTD | 2023-12-31 |
|---|---|
| Operating Revenue | $5.49MM |
| Operating Expenses | $57.64MM |
| Operating Income | $-52.15MM |
| Non-Operating Income | $1.42MM |
| Interest Expense | $1.25MM |
| R&D Expense | $40.80MM |
| Income(Loss) | $-50.73MM |
| Profit(Loss) | $-50.73MM |
| Stockholders Equity | $37.09MM |
| Assets | $61.53MM |
| Operating Cash Flow | $-39.96MM |
| Investing Cash Flow | $25.00MM |
| Financing Cash Flow | $11.86MM |
| Earnings Per Share* | $-1.11 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.